Research Article

Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis

Table 2

Meta-analysis results.

OutcomeVariablesNumber of studiesNumber of patientsModelHR (95% CI)HeterogeneityPublication bias
(%)Begg’s Egger’s

OSAll203232Random0.77 (0.64, 0.93)56.80.0010.3810.358
Tumor type
NSCLC4613Random0.42 (0.17, 1.08)82.20.0011.0000.340
HCC2173Fixed0.65 (0.49, 0.86)2.600.311
CRC5896Fixed0.85 (0.69, 1.04)00.5840.8060.679
RCC2738Fixed0.65 (0.38, 1.12)00.624
AML2200Fixed1.77 (1.15, 2.72)00.666
Ethnicity
Asian121353Fixed0.76 (0.66, 0.88)37.00.1290.8370.668
Caucasian81879Random0.77 (0.57, 1.05)73.8<0.0010.5360.479
Sample
Circulation4273Fixed1.65 (1.09, 2.51)00.6470.7340.162
Tissue162959Random0.71 (0.60, 0.85)51.10.010.1370.068
Assay method
qRT-PCR172940Random0.72 (0.58, 0.90)61.2<0.0010.3030.250
ISH3292Fixed1.00 (0.75, 1.34)00.8041.0000.646
Analysis type
Multivariate71870Fixed0.81 (0.72, 0.90)11.00.3440.0720.095
Univariate71530Random0.89 (0.79, 1.00)66.40.0071.0000.990
HR estimated
HRs reported142897Random0.78 (0.64, 0.96)67.8<0.0010.2740.461
K-M curve6335Fixed0.79 (0.53, 1.18)00.6661.0000.705

DFSAll7755Fixed0.64 (0.48, 0.85)00.7800.1330.203
Tumor type
NSCLC2101Fixed0.49 (0.26, 0.93)00.983
ESCC2274Fixed0.77 (0.48, 1.24)00.629
Ethnicity
Asian4417Fixed0.64 (0.44, 0.94)00.5320.3080.081
Caucasian3419Fixed0.63 (0.41, 0.97)00.5991.0000.874
Analysis type
Multivariate3509Fixed0.65 (0.45, 0.94)00.3840.2960.360
Univariate4619Random0.67 (0.50, 0.90)88.0<0.0010.7340.586

RFS/PFS/DSSAll132014Random0.70 (0.50, 0.98)84.8<0.0010.3600.288
Tumor type
CRC5882Fixed0.74 (0.59, 0.94)47.30.1081.0000.514
NSCLC2382Random0.43 (0.03, 7.25)97.2<0.001
Ethnicity
Asian2313Fixed0.69 (0.48, 0.99)00.417
Caucasian111701Random0.69 (0.46, 1.02)87.1<0.0010.2130.267
Analysis type
Multivariate71531Random0.71 (0.50, 1.02)83.2<0.0010.2300.281
Univariate5651Random0.89 (0.77, 1.02)81.4<0.0010.4620.872

CRC: colorectal cancer; HCC: hepatocellular carcinoma, NSCLC: non-small cell lung cancer; cRCC: clear renal cell carcinoma; ESCC: esophageal squamous cell carcinoma; AML: acute myeloid leukemia; K-M curve: Kaplan-Meier curve; fixed: fixed-effects model; random: random-effects model.